Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F de Man

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
American Heart Journal|December 16, 2014
Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trialMing Kai Lam, Hanim Sen, K Gert van Houwelingen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 24, 2014
Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trialK Gert van Houwelingen, Hanim Sen, Ming Kai Lam, et al.
European Heart Journal Open|February 17, 2025
Sex and age-specific 10-year mortality after coronary stenting: an analysis of two randomized trialsTineke H Pinxterhuis, Eline H Ploumen, Carine J M Doggen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 3, 2020
Three contemporary thin-strut drug-eluting stents implanted in severely calcified coronary lesions of participants in a randomized all-comers trialRosaly A Buiten, Eline H Ploumen, Paolo Zocca, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 24, 2011
Incidence of periprocedural myocardial infarction following stent implantation: comparison between first- and second-generation drug-eluting stentsKenneth Tandjung, Mounir W Z Basalus, Esther Muurman, et al.
JAMA Cardiology|May 22, 2019
Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT TrialRosaly A Buiten, Eline H Ploumen, Paolo Zocca, et al.
International Journal of Cardiology|August 30, 2014
Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and non-enrolled TWENTE registryHanim Sen, Ming Kai Lam, Kenneth Tandjung, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 15, 2015
Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA studyMarlies M Kok, Clemens von Birgelen, Ming Kai Lam, et al.
International Journal of Cardiology|May 27, 2018
High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPTPaolo Zocca, Marlies M Kok, Liefke C van der Heijden, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 19, 2019
Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes studyEline H Ploumen, Rosaly A Buiten, Marlies M Kok, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
American Heart Journal|December 16, 2014
Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trialMing Kai Lam, Hanim Sen, K Gert van Houwelingen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 24, 2014
Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trialK Gert van Houwelingen, Hanim Sen, Ming Kai Lam, et al.
European Heart Journal Open|February 17, 2025
Sex and age-specific 10-year mortality after coronary stenting: an analysis of two randomized trialsTineke H Pinxterhuis, Eline H Ploumen, Carine J M Doggen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 3, 2020
Three contemporary thin-strut drug-eluting stents implanted in severely calcified coronary lesions of participants in a randomized all-comers trialRosaly A Buiten, Eline H Ploumen, Paolo Zocca, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 24, 2011
Incidence of periprocedural myocardial infarction following stent implantation: comparison between first- and second-generation drug-eluting stentsKenneth Tandjung, Mounir W Z Basalus, Esther Muurman, et al.
JAMA Cardiology|May 22, 2019
Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT TrialRosaly A Buiten, Eline H Ploumen, Paolo Zocca, et al.
International Journal of Cardiology|August 30, 2014
Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and non-enrolled TWENTE registryHanim Sen, Ming Kai Lam, Kenneth Tandjung, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 15, 2015
Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA studyMarlies M Kok, Clemens von Birgelen, Ming Kai Lam, et al.
International Journal of Cardiology|May 27, 2018
High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPTPaolo Zocca, Marlies M Kok, Liefke C van der Heijden, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 19, 2019
Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes studyEline H Ploumen, Rosaly A Buiten, Marlies M Kok, et al.
Pageof 8